These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30415518)

  • 1. Clinical characteristics and outcomes of hepatocellular carcinoma: results from prospective study, from a tertiary referral center in 
Sri Lanka.
    Bulathsinhala BKS; Siriwardana RC; Gunetilleke MB; Niriella MA; Dassanayake A
    Ceylon Med J; 2018 Sep; 63(3):133-138. PubMed ID: 30415518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: a prospective study.
    Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage C; Gunathilaka B; Jayathunge S; de Silva HJ
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):401-5. PubMed ID: 26256085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.
    Than NN; Ghazanfar A; Hodson J; Tehami N; Coldham C; Mergental H; Manas D; Shah T; Newsome PN; Reeves H; Shetty S
    QJM; 2017 Feb; 110(2):73-81. PubMed ID: 27634970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis.
    Tan DJH; Ng CH; Lin SY; Pan XH; Tay P; Lim WH; Teng M; Syn N; Lim G; Yong JN; Quek J; Xiao J; Dan YY; Siddiqui MS; Sanyal AJ; Muthiah MD; Loomba R; Huang DQ
    Lancet Oncol; 2022 Apr; 23(4):521-530. PubMed ID: 35255263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
    Jun TW; Yeh ML; Yang JD; Chen VL; Nguyen P; Giama NH; Huang CF; Hsing AW; Dai CY; Huang JF; Chuang WL; Roberts LR; Yu ML; Nguyen MH
    Liver Int; 2018 May; 38(5):895-902. PubMed ID: 29045023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
    Önnerhag K; Nilsson PM; Lindgren S
    Scand J Gastroenterol; 2014 Sep; 49(9):1111-8. PubMed ID: 24990583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India.
    Musunuri B; Shetty S; Bhat G; Udupa K; Pai A
    Indian J Gastroenterol; 2022 Apr; 41(2):127-134. PubMed ID: 35226292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period.
    Pais R; Fartoux L; Goumard C; Scatton O; Wendum D; Rosmorduc O; Ratziu V
    Aliment Pharmacol Ther; 2017 Nov; 46(9):856-863. PubMed ID: 28857208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-center prospective survey of hepatocellular carcinoma in Kerala: More than 1,200 cases.
    Koshy A; Devadas K; Panackel C; Philip M; Premaletha N; Zacharias P; Ramachandran TM; Gopalakrishna R; Mukkada RJ; Philips CA; Augustine P; Krishnakumar R; Sebastian B; Chettupuzha AP; Sadasivan S; Thomas GK; Siyad I; Sandesh K; Abhilash VB; Antony R; Kandathil JC; Pratap T; Mahadevan P;
    Indian J Gastroenterol; 2023 Apr; 42(2):233-240. PubMed ID: 37154853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.
    Kimura T; Tanaka N; Fujimori N; Sugiura A; Yamazaki T; Joshita S; Komatsu M; Umemura T; Matsumoto A; Tanaka E
    World J Gastroenterol; 2018 Apr; 24(13):1440-1450. PubMed ID: 29632425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of macrovascular invasion in hepatocellular carcinoma.
    Guarino M; Cucchetti A; Pontillo G; Farinati F; Benevento F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Rodolfo S; Cabibbo G; Marra F; Mega A; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Missale G; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Oliveri F; Trevisani F; Giannini EG; Morisco F;
    Eur J Clin Invest; 2021 Jul; 51(7):e13542. PubMed ID: 33755196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India.
    Paul SB; Chalamalasetty SB; Vishnubhatla S; Madan K; Gamanagatti SR; Batra Y; Gupta SD; Panda SK; Acharya SK
    Oncology; 2009; 77(3-4):162-71. PubMed ID: 19641335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.
    Degasperi E; Colombo M
    Lancet Gastroenterol Hepatol; 2016 Oct; 1(2):156-164. PubMed ID: 28404072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptogenic cirrhosis is the leading cause for listing for liver transplantation in Sri Lanka.
    Siriwardana RC; Niriella MA; Liyanage CA; Wijesuriya SR; Gunathilaka B; Dassanayake AS; De Silva HJ
    Indian J Gastroenterol; 2013 Nov; 32(6):397-9. PubMed ID: 23999684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.
    Rinaldi L; Nascimbeni F; Giordano M; Masetti C; Guerrera B; Amelia A; Fascione MC; Ballestri S; Romagnoli D; Zampino R; Nevola R; Baldelli E; Iuliano N; Rosato V; Lonardo A; Adinolfi LE
    World J Gastroenterol; 2017 Feb; 23(8):1458-1468. PubMed ID: 28293093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Treatment of Localized Infiltrative Hepatocellular Carcinoma Developing on Cirrhosis.
    Nault JC; Nkontchou G; Nahon P; Grando V; Bourcier V; Barge S; Ziol M; Sellier N; Ganne-Carrie N; Seror O
    Ann Surg Oncol; 2016 Jun; 23(6):1906-15. PubMed ID: 26732275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.